This week at the Society of Interventional Radiology's 35th Annual Scientific Meeting, Mayo Clinic researchers released the results of a 119-patient study that used MR-guided Focused Ultrasound* to treat uterine fibroids.
The study covered a period of nearly three years, with patient feedback collected via phone interview 12 months post procedure. Of the 89 patients interviewed, 97% reported improvement in their symptoms, and 90% rated their improvement as either considerable or excellent. Over the next three years, the researchers will gather additional feedback about symptom relief from these patients at the 24-month and 36-month milestones.
Mayo Clinic will compare the results of this study with those reported for Myomectomy and Uterine Artery Embolization. They also plan to investigate the efficacy of MR-guided FUS in treating other uterine conditions, such as adenomyosis (a condition in which tissue that normally lines the uterus also grows within the muscular walls of the uterus).
To read the press release in its entirety, click here.
*The use of MR-guided Focused Ultrasound for Fibroids is the first FDA approved indication. There are clinical trials currently ing MR-guided FUS for the treatment of Bone Metastases, Breast Tumors and Prostate Cancer.